+

CA2377665A1 - Methodes et compositions permettant d'analyser des analytes - Google Patents

Methodes et compositions permettant d'analyser des analytes Download PDF

Info

Publication number
CA2377665A1
CA2377665A1 CA002377665A CA2377665A CA2377665A1 CA 2377665 A1 CA2377665 A1 CA 2377665A1 CA 002377665 A CA002377665 A CA 002377665A CA 2377665 A CA2377665 A CA 2377665A CA 2377665 A1 CA2377665 A1 CA 2377665A1
Authority
CA
Canada
Prior art keywords
mutant
binding
enzyme
analyte
sah
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002377665A
Other languages
English (en)
Inventor
Chong-Sheng Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Atomics Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/347,878 external-priority patent/US6376210B1/en
Application filed by Individual filed Critical Individual
Publication of CA2377665A1 publication Critical patent/CA2377665A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

L'invention concerne des compositions et des méthodes permettant d'analyser des analytes, de préférence, des analytes à petites molécules. Ces méthodes d'analyse utilisent, au lieu d'anticorps ou de molécules qui se lient aux analytes ou aux substrats cibles, des enzymes modifiées, appelées enzymes de piégeage par substrat. Ces enzymes modifiées retiennent une affinité de liaison ou présentent une affinité de liaison améliorée pour un substrat ou un analyte cible, mais elles présentent une activité catalytique atténuée par rapport au substrat ou à l'analyte. L'invention concerne également ces enzymes modifiées, et notamment, des S-adénosylhomocystéine (SAH) hydrolases mutantes, retenant sensiblement une affinité de liaison ou présentant une affinité de liaison améliorée pour l'homocystéine ou la S-adénosylhomocystéine, mais présentant une activité catalytique atténuée. L'invention concerne en outre des conjugués des enzymes modifiées et une substance auxiliaire, tel que des agents assistant à la purification ou à la liaison sur un support solide.
CA002377665A 1999-07-06 2000-06-30 Methodes et compositions permettant d'analyser des analytes Abandoned CA2377665A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/347,878 US6376210B1 (en) 1999-07-06 1999-07-06 Methods and compositions for assaying analytes
US09/347,878 1999-07-06
US45720599A 1999-12-06 1999-12-06
US09/457,205 1999-12-06
PCT/US2000/018057 WO2001002600A2 (fr) 1999-07-06 2000-06-30 Methodes et compositions permettant d'analyser des analytes

Publications (1)

Publication Number Publication Date
CA2377665A1 true CA2377665A1 (fr) 2001-01-11

Family

ID=26995460

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002377665A Abandoned CA2377665A1 (fr) 1999-07-06 2000-06-30 Methodes et compositions permettant d'analyser des analytes

Country Status (4)

Country Link
AU (1) AU5781800A (fr)
CA (1) CA2377665A1 (fr)
GB (1) GB2368641B (fr)
WO (1) WO2001002600A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486007A (zh) * 2018-03-22 2018-09-04 嘉兴益诺康生物科技有限公司 一种用于降低血尿酸的干酪乳杆菌株、益生菌组合物及其应用

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192729B2 (en) 1999-07-06 2007-03-20 General Atomics Methods for assaying homocysteine
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
EP1495123B1 (fr) 2002-03-26 2013-10-30 Zensun (Shanghai) Science and Technology Limited Procedes fondes sur l'utilisation de erbb3 et compositions associees de traitement des neoplasmes
US7485307B2 (en) 2002-06-17 2009-02-03 The Regents Of The University Of Colorado Human cystathionine β-synthase variants and methods of production thereof
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
CA2511316A1 (fr) * 2002-12-31 2004-07-22 Rodi Pharma, Inc. Jeux ordonnes d'enzymes de liaison et procedes proteomiques haut debit
US8476034B2 (en) 2003-07-10 2013-07-02 General Atomics Methods and compositions for assaying homocysteine
US7097968B2 (en) 2003-07-10 2006-08-29 General Atomics Methods and compositions for assaying homocysteine
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US9675678B2 (en) 2013-01-29 2017-06-13 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for treatment of homocystinuria
WO2015006934A1 (fr) * 2013-07-17 2015-01-22 国家纳米科学中心 Puce de criblage de médicaments à petites molécules, procédé de construction correspondant et application correspondante
CN104111337B (zh) * 2014-05-07 2016-01-06 山东博科生物产业有限公司 抗干扰性强的同型半胱氨酸检测试剂盒
CN106434786B (zh) * 2015-08-21 2020-08-25 光明乳业股份有限公司 一种由干酪乳杆菌发酵制备胞外多糖的方法
RS66106B1 (sr) 2015-11-09 2024-11-29 Univ Colorado Regents Kompozicije i postupci za lečenje homocistinurije
MX2019012347A (es) 2017-04-17 2020-01-15 Univ Colorado Regents Optimizacion de terapia de reemplazo enzimatico para el tratamiento de la homocistinuria.
CN110097928B (zh) * 2019-04-17 2022-03-11 广东省科学院微生物研究所(广东省微生物分析检测中心) 一种基于肠道菌群预测组织微量元素含量的预测方法和预测模型
CN114460159B (zh) * 2022-02-17 2023-11-03 河南中医药大学 基于photo-ATRP信号放大策略的ALP活性检测试剂盒及其使用方法
CN118028631B (zh) * 2024-02-07 2024-12-20 江苏海普功能材料有限公司 从三元电池废液中回收锰的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008137A1 (fr) * 1987-04-10 1988-10-20 The Flinders University Of South Australia Dosage ionique dans des fluides
GB9022304D0 (en) * 1990-10-15 1990-11-28 Ares Serono Res & Dev Ltd Assay technique
CA2128512C (fr) * 1992-01-22 1999-12-07 Erling Sundrehagen Dosage de l'homocysteine
US5679548A (en) * 1993-02-02 1997-10-21 The Scripps Research Institute Methods for producing polypeptide metal binding sites and compositions thereof
JP2001508647A (ja) * 1996-11-04 2001-07-03 メルク フロスト カナダ アンド カンパニー ヒドロラーゼ結合アッセイ
DE19757571A1 (de) * 1997-12-23 1999-06-24 Hartmut Prof Dr Oswald Ein einfacher und hochempfindlicher Nachweis von Adenosin in kleinen Proben

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108486007A (zh) * 2018-03-22 2018-09-04 嘉兴益诺康生物科技有限公司 一种用于降低血尿酸的干酪乳杆菌株、益生菌组合物及其应用

Also Published As

Publication number Publication date
GB0200425D0 (en) 2002-02-27
WO2001002600A9 (fr) 2002-07-25
WO2001002600A2 (fr) 2001-01-11
GB2368641B (en) 2004-10-06
AU5781800A (en) 2001-01-22
GB2368641A (en) 2002-05-08
WO2001002600A3 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
US6610504B1 (en) Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
CA2377665A1 (fr) Methodes et compositions permettant d'analyser des analytes
US20040014083A1 (en) Detection of heteroduplex polynucleotides using mutant nucleic acid repair enzymes with attenuated catalytic activity
JP3337693B2 (ja) 生物学的サンプルの高特異性ホモシステインアッセイ
Baxi et al. Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein
Chatterjee et al. Chemical approaches for studying histone modifications
US6376210B1 (en) Methods and compositions for assaying analytes
JP5415264B2 (ja) 検出可能な核酸タグ
CN112567028A (zh) 多部分萤光素酶
JP2007508844A (ja) 治療用化合物の同定のための方法および組成物
US8741559B2 (en) Cellular assay employing detectable protein
JPH08507686A (ja) 遺伝子操作酵素及びそれらの診断アッセイ用結合体
US8329412B2 (en) Method for determining NAE1-beta or NAE1-beta/NEDD8 complex
CN115947862A (zh) Sh2超亲体蛋白及其与固相缀合所形成的缀合物
AU2003290715A1 (en) Method for identifying risk of melanoma and treatments thereof
JPWO2006135096A1 (ja) 部位特異的にタンパク質にチロシンアナログを導入する方法
WO1999036532A1 (fr) Procede pour detecter des activites acetyltransferase et desacetylase, ainsi que procede pour cribler des inhibiteurs ou des accelerateurs de ces enzymes
JPS63282659A (ja) 核酸の測定方法および測定剤
US20060246529A1 (en) Methods and compositions for assaying homocysteine
US20190212340A1 (en) An elisa-like assay for quantifying enzymatic activities of mono-adp-ribosyltransferases
WO1997017443A9 (fr) Proteine associee a la huntingtine
Jin et al. Interaction of apurinic/apyrimidinic endonuclease 2 (Apn2) with Myh1 DNA glycosylase in fission yeast
CZ289523B6 (cs) Způsob detekce přítomnosti katalyticky aktivní a katalyticky inaktivní methylthioadenosin fosforylázy
JP2006500021A (ja) ｃＡＭＰ分析
US20210261603A1 (en) Site-specific serine adp-ribosylated proteins and peptides and method for producing the same

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载